Atopic Dermatitis Clinical Trials

The primary objective for part A of the study is to characterize the safety and pharmacokinetics (PK) of dupilumab administered as a single dose in pediatric patients, 6 months to less than 6 years of age with severe atopic dermatitis (AD). The primary objective for part B of the study ...

A research study is now underway in San Diego to evaluate an investigational medication for those who have failed to respond to prior treatments for Eczema, also known as Atopic Dermatitis.

Have you had moderate to severe atopic dermatitis for at least 1 year? A clinical trial designed to evaluate the safety and effectiveness of a new investigational medication under development for adult patients with moderate-to-severe atopic dermatitis is currently being conducted. All subjects will receive injections of trial medication every ...

The aim of the study is to assess the safety of topical application in the treatment of atopic dermatitis.

Study is for an investigational eczema medication that is delivered as an injection at the doctors office.

If you are 18 years or older and struggle with eczema, you may qualify for a new clinical research study. The study is for an investigational eczema medication that is delivered as an injection at the doctor's office.

This is a randomized, double-blind, pilot study of a total of 44 subjects with AD (22 with intrinsic and 22 with extrinsic AD) consisting of 2 phases. Subjects will be randomized (2:1) to either receive secukinumab 300 mg or placebo via subcutaneous injection using 2 prefilled syringes.

The objective of this study is to evaluate the potential of DSXS to suppress HPA axis function in patients with moderate to severe atopic dermatitis. The secondary objectives are to evaluate to evaluate adverse event (AE) profiles of DSXS administered to patients with moderate to severe atopic dermatitis.

This is a multicenter, randomized, double-blind, placebo-controlled study to be conducted in the United States in subjects with treatment-resistant pruritus diagnosed with atopic dermatitis.

The purpose of this study is to assess the efficacy and safety of OPA-15406 ointment in patients with atopic dermatitis.